These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
83. Phytocannabinoids for the Treatment of Neuropathic Pain: A Scoping Review of Randomised Controlled Trials Published Between 2012 and 2023. Lewis M; Baroutian S; Hanning SM Curr Pain Headache Rep; 2024 Mar; 28(3):109-118. PubMed ID: 38095748 [TBL] [Abstract][Full Text] [Related]
84. Cannabidiol, but Not Δ9-Tetrahydrocannabinol, Has Strain- and Genotype-Specific Effects in Models of Psychosis. Mielnik CA; Li CK; Ramsey AJ; Salahpour A; Burnham WM; Ross RA Cannabis Cannabinoid Res; 2024 Feb; 9(1):174-187. PubMed ID: 36251462 [No Abstract] [Full Text] [Related]
85. An experimental randomized study on the analgesic effects of pharmaceutical-grade cannabis in chronic pain patients with fibromyalgia. van de Donk T; Niesters M; Kowal MA; Olofsen E; Dahan A; van Velzen M Pain; 2019 Apr; 160(4):860-869. PubMed ID: 30585986 [TBL] [Abstract][Full Text] [Related]
87. Medicinal Cannabis (MedCan 3): a randomised, multicentre, double-blind, placebo-controlled trial to assess THC/CBD (1:20) to relieve symptom burden in patients with cancer-a study protocol for a randomised controlled trial. Gurgenci T; Hardy J; Huggett G; Foster K; Pelecanos A; Greer R; Philip J; Haywood A; Mendis R; Yates P; Good P Trials; 2024 May; 25(1):293. PubMed ID: 38693590 [TBL] [Abstract][Full Text] [Related]
88. Interactions between cannabidiol and Δ Anderson LL; Low IK; McGregor IS; Arnold JC Br J Pharmacol; 2020 Sep; 177(18):4261-4274. PubMed ID: 32608111 [TBL] [Abstract][Full Text] [Related]
89. A validated method for the simultaneous quantification of cannabidiol, Δ Kevin RC; Vogel R; Doohan P; Berger M; Amminger GP; McGregor IS Drug Test Anal; 2021 Mar; 13(3):614-627. PubMed ID: 33095968 [TBL] [Abstract][Full Text] [Related]
90. Effect of Cannabidiol and Δ9-Tetrahydrocannabinol on Driving Performance: A Randomized Clinical Trial. Arkell TR; Vinckenbosch F; Kevin RC; Theunissen EL; McGregor IS; Ramaekers JG JAMA; 2020 Dec; 324(21):2177-2186. PubMed ID: 33258890 [TBL] [Abstract][Full Text] [Related]
91. Δ Hodges RM; Chase KJ; Tripson MA; Bingham S; Woolley-Roberts M; Guy GW; Soderstrom K Cannabis Cannabinoid Res; 2023 Oct; 8(5):790-801. PubMed ID: 36125410 [No Abstract] [Full Text] [Related]
92. Effects of Δ9-THC and cannabidiol vapor inhalation in male and female rats. Javadi-Paydar M; Nguyen JD; Kerr TM; Grant Y; Vandewater SA; Cole M; Taffe MA Psychopharmacology (Berl); 2018 Sep; 235(9):2541-2557. PubMed ID: 29907926 [TBL] [Abstract][Full Text] [Related]
93. THC and CBD produce divergent effects on perception and panic behaviours via distinct cortical molecular pathways. Szkudlarek HJ; Rodríguez-Ruiz M; Hudson R; De Felice M; Jung T; Rushlow WJ; Laviolette SR Prog Neuropsychopharmacol Biol Psychiatry; 2021 Jan; 104():110029. PubMed ID: 32623021 [TBL] [Abstract][Full Text] [Related]
94. Interactions between cannabidiol and Δ Todd SM; Zhou C; Clarke DJ; Chohan TW; Bahceci D; Arnold JC Eur Neuropsychopharmacol; 2017 Feb; 27(2):132-145. PubMed ID: 28043732 [TBL] [Abstract][Full Text] [Related]
95. A tale of two cannabinoids: the therapeutic rationale for combining tetrahydrocannabinol and cannabidiol. Russo E; Guy GW Med Hypotheses; 2006; 66(2):234-46. PubMed ID: 16209908 [TBL] [Abstract][Full Text] [Related]
96. Effects of a combination of cannabidiol and delta-9-tetrahydrocannabinol on key biological functions of HTR-8/SVneo extravillous trophoblast cells. Alves P; Amaral C; Teixeira N; Correia-da-Silva G Toxicology; 2023 Aug; 495():153614. PubMed ID: 37567336 [TBL] [Abstract][Full Text] [Related]
97. Cannabinoids in Oral Fluid: Limiting Potential Sources of Cannabidiol Conversion to Δ9- and Δ8-Tetrahydrocannabinol. Coulter C; Wagner JR J Anal Toxicol; 2021 Sep; 45(8):807-812. PubMed ID: 34137890 [TBL] [Abstract][Full Text] [Related]
98. Potency trends of Δ9-tetrahydrocannabinol, cannabidiol and cannabinol in cannabis in the Netherlands: 2005-15. Niesink RJ; Rigter S; Koeter MW; Brunt TM Addiction; 2015 Dec; 110(12):1941-50. PubMed ID: 26234170 [TBL] [Abstract][Full Text] [Related]
99. Cannabinoid receptor expression in non-small cell lung cancer. Effectiveness of tetrahydrocannabinol and cannabidiol inhibiting cell proliferation and epithelial-mesenchymal transition in vitro. Milian L; Mata M; Alcacer J; Oliver M; Sancho-Tello M; Martín de Llano JJ; Camps C; Galbis J; Carretero J; Carda C PLoS One; 2020; 15(2):e0228909. PubMed ID: 32049991 [TBL] [Abstract][Full Text] [Related]
100. Fatty acid-binding proteins (FABPs) are intracellular carriers for Δ9-tetrahydrocannabinol (THC) and cannabidiol (CBD). Elmes MW; Kaczocha M; Berger WT; Leung K; Ralph BP; Wang L; Sweeney JM; Miyauchi JT; Tsirka SE; Ojima I; Deutsch DG J Biol Chem; 2015 Apr; 290(14):8711-21. PubMed ID: 25666611 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]